0001127602-19-020530.txt : 20190603
0001127602-19-020530.hdr.sgml : 20190603
20190603173556
ACCESSION NUMBER: 0001127602-19-020530
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190530
FILED AS OF DATE: 20190603
DATE AS OF CHANGE: 20190603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CRAWFORD SALLY
CENTRAL INDEX KEY: 0001199735
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33462
FILM NUMBER: 19874486
MAIL ADDRESS:
STREET 1: C/O HOLOGIC, INC.
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSULET CORP
CENTRAL INDEX KEY: 0001145197
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043523891
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 NAGOG PARK
CITY: ACTON
STATE: MA
ZIP: 01720
BUSINESS PHONE: 978-600-7000
MAIL ADDRESS:
STREET 1: 100 NAGOG PARK
CITY: ACTON
STATE: MA
ZIP: 01720
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-05-30
0001145197
INSULET CORP
PODD
0001199735
CRAWFORD SALLY
C/O INSULET CORPORATION
100 NAGOG PARK
ACTON
MA
01720
1
Common Stock
2019-05-30
4
A
0
1726
0
A
28469
D
Common Stock
2019-05-31
4
M
0
5235
28.87
A
33704
D
Common Stock
2019-05-31
4
M
0
3587
40.60
A
37291
D
Common Stock
2019-05-31
4
M
0
5525
27.37
A
42816
D
Common Stock
2019-05-31
4
M
0
2000
20.90
A
44816
D
Common Stock
2019-05-31
4
M
0
4000
17.75
A
48816
D
Common Stock
2019-05-31
4
M
0
4000
30.04
A
52816
D
Common Stock
2019-05-31
4
M
0
4000
35.11
A
56816
D
Common Stock
2019-05-31
4
S
0
28347
108.60
D
28469
D
Stock Option (Right to Buy)
28.87
2019-05-31
4
M
0
5235
0
D
2017-04-30
2026-05-11
Common Stock
5235
0
D
Stock Option (Right to Buy)
40.60
2019-05-31
4
M
0
3587
0
D
2018-04-30
2027-05-17
Common Stock
3587
0
D
Stock Option (Right to Buy)
27.37
2019-05-31
4
M
0
5525
0
D
2025-05-13
Common Stock
5525
0
D
Stock Option (Right to Buy)
20.90
2019-05-31
4
M
0
2000
0
D
2021-05-12
Common Stock
2000
0
D
Stock Option (Right to Buy)
17.75
2019-05-31
4
M
0
4000
0
D
2022-06-01
Common Stock
4000
0
D
Stock Option (Right to Buy)
30.04
2019-05-31
4
M
0
4000
0
D
2023-06-03
Common Stock
4000
0
D
Stock Option (Right to Buy)
35.11
2019-05-31
4
M
0
4000
0
D
2024-06-02
Common Stock
4000
0
D
Annual equity award in the form of restricted stock units ("RSUs"). RSUs vest in full on April 30, 2020 and are settled in shares of common stock on a one-for-one basis.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2019.
The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $106.965 to $110.395. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
This option is subject to a three-year vesting period with 50% of the total award vesting on April 30, 2016, 25% of the total award vesting on April 30, 2017 and 25% of the total award vesting on April 30, 2018, subject to continued service as a director or consultant.
This option is subject to a three-year vesting period with 50% of the total award vesting on April 30, 2012, 25% of the total award vesting on April 30, 2013 and 25% of the total award vesting on April 30, 2014, subject to continued service as a director or consultant.
This option is subject to a three-year vesting period with 50% of the total award vesting on April 30, 2013, 25% of the total award vesting on April 30, 2014 and 25% of the total award vesting on April 30, 2015, subject to continued service as a director or consultant.
This option is subject to the following vesting schedule: 50% of the total award shall vest on April 30, 2014, 25% of the total award shall vest on April 30, 2015 and 25% of the total award shall vest on April 30, 2016, subject to continued service as a director or consultant.
This option is subject to a three-year vesting period with 50% of the total award vesting on April 30, 2015, 25% of the total award vesting on April 30, 2016 and 25% of the total award vesting on April 30, 2017, subject to continued service as a director or consultant.
/s/ John W. Kapples, attorney-in-fact
2019-06-03
EX-24
2
doc1.txt
POWER OF ATTORNEY (PUBLIC): POA
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that the undersigned hereby
constitutes and appoints Shacey Petrovic, John W. Kapples, Wayde D.
McMillan and Keith Bilezerian, and any one of them acting singly, the
true and lawful attorneys-in-fact and agents, with full power of
substitution and resubstitution, for the undersigned and in the
undersigned's name, place and stead, in any and all capacities (until
revoked in writing) to execute for and on behalf of the undersigned, in any
any and all of the undersigned's capacities any and all statements on
Forms 3, 4 and 5 with respect to the undersigned's holdings of and
transactions in securities issued by Insulet Corporation (the "Company")
in accordance with Sections 16(a) of the Securities Exchange Act of 1934,
as amended (the "Exchange Act"), and any and all regulations promulgated
thereunder, and to file the same, with all exhibits thereto, and any other
documents in connection therewith, with the Securities and Exchange
Commission, and with any other entity when and if such is mandated by the
Exchange Act or by the By-laws of the National Association of Securities
Dealers, granting unto said attorneys-in-fact and agents full power and
authority to do and perform each and every act and thing requisite and
necessary fully to all intents and purposes as the undersigned might or
could do in person thereby ratifying and confirming all that said
attorneys-in-fact and agents, or their substitute or substitutes, may lawfully
do or cause to be done by virtue hereof.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to
the undersigned's holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, this Power of Attorney has been signed as of
March 26, 2019.
Signature: /s/ Sally Crawford
Name: Sally Crawford